Contents

• COMMITTEE ON THE ASSESSMENT OF WARTIME EXPOSURE TO HERBICIDES IN VIETNAM
• Introduction
• Background
• RFP Statement of Work
• Supplemental Information
• Background on Methods
  • Epidemiologic Study Designs
  • Past Exposure Assessment
• Available Data
• Potential Approaches
• Validation of Exposure Assessment Approaches
• Evaluation Criteria
  • Context (10%)
  • Technical Merit (35%)
  • Feasibility and Validation (25%)
  • Personnel and Experience (20%)
  • Cost and Timeline (10%)
• Research Products
• References
• Appendix The Assessment of Exposure to Herbicides Among Vietnam Veterans: A Review and Recommendations for Future Studies

Support for this study was provided by the Department of Veterans Affairs (Contract No. V101(93)P-1331). The views, opinions, and/or findings contained in this report are those of the Committee on the Assessment of Wartime Exposure to Herbicides in Vietnam and should not be construed as an official Department of Veterans Affairs position, policy, or decision unless so designated by other documentation.

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competencies and with regard for appropriate balance.

This report has been reviewed by a group other than the authors according to procedures approved by a Report Review Committee consisting of members of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.

The Institute of Medicine was chartered in 1970 by the National Academy of Sciences to enlist distinguished members of the appropriate professions in the examination of policy matters pertaining to the health of the public. In this, the Institute acts under the Academy's 1863 congressional charter responsibility to be an adviser to the federal government and its own initiative in identifying issues of medical care, research, and education. Dr. Kenneth I. Shine is president of the Institute of Medicine.